Caprock Group LLC Makes New $3.57 Million Investment in Cencora, Inc. $COR

Caprock Group LLC acquired a new stake in Cencora, Inc. (NYSE:COR) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 12,222 shares of the company’s stock, valued at approximately $3,572,000.

Several other large investors have also modified their holdings of the company. Atlantic Edge Private Wealth Management LLC raised its position in Cencora by 70.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock valued at $25,000 after purchasing an additional 35 shares during the last quarter. Cloud Capital Management LLC acquired a new position in Cencora in the third quarter valued at $31,000. Vermillion & White Wealth Management Group LLC raised its holdings in shares of Cencora by 69.4% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares during the last quarter. Westside Investment Management Inc. boosted its stake in shares of Cencora by 200.0% during the third quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after buying an additional 70 shares during the period. Finally, Copia Wealth Management boosted its stake in shares of Cencora by 505.0% during the third quarter. Copia Wealth Management now owns 121 shares of the company’s stock worth $38,000 after buying an additional 101 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.

Cencora Trading Up 1.6%

Shares of Cencora stock opened at $365.89 on Thursday. The company has a 50-day moving average of $346.79 and a two-hundred day moving average of $327.66. Cencora, Inc. has a 12-month low of $237.71 and a 12-month high of $377.54. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The stock has a market cap of $70.98 billion, a PE ratio of 43.98, a price-to-earnings-growth ratio of 1.66 and a beta of 0.68.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. The business had revenue of $85.93 billion for the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.73 EPS. On average, research analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a $0.60 dividend. The ex-dividend date is Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s dividend payout ratio (DPR) is currently 28.85%.

Analyst Upgrades and Downgrades

Several research firms have commented on COR. Barclays began coverage on Cencora in a research note on Monday, December 8th. They set an “overweight” rating and a $400.00 price objective for the company. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Evercore lowered their price objective on shares of Cencora from $440.00 to $420.00 and set an “outperform” rating on the stock in a research report on Thursday, February 5th. Robert W. Baird set a $415.00 price objective on shares of Cencora in a research report on Tuesday, January 13th. Finally, Mizuho lifted their target price on shares of Cencora from $340.00 to $380.00 and gave the company an “outperform” rating in a report on Thursday, November 6th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $396.92.

Insider Transactions at Cencora

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $366.64, for a total value of $1,868,397.44. Following the sale, the chief executive officer owned 65,746 shares of the company’s stock, valued at $24,105,113.44. This represents a 7.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the completion of the sale, the executive vice president owned 23,891 shares in the company, valued at $8,173,111.10. This represents a 12.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 20,316 shares of company stock valued at $7,151,265 in the last 90 days. 0.38% of the stock is currently owned by insiders.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.